| 摘要 |
The present invention provides a method for treating or preventing a disorder typified by an immunodificiency (e.g. HIV), wherein the patient is administered a COX-2 inhibitor or derivative or pharmaceutically acceptable salt thereof, preferably diisopropylfluorophasphaate, L-745337, rofecoxi, NS 398, SC 58125, etodolac, meloxicam, celecoxib flusolide or nimesulide, and compositions and products containing the same or use of the same in preparing medicaments and for treatment. |
| 申请人 |
LAURAS AS;JONES, ELIZABETH, LOUISE;TASKEN, KJETIL;MOUTSCHEN, MICHEL;RAHMOUNI-PIETTE, SOUAD;AANDAHL, EINAR, MARTIN;AUKRUST, PAAL;FROELAND, STIG, S.;JOHANSSON, CHRISTIAN, CARL;HANSSON, VIDAR;KLAVENESS, JO |
发明人 |
TASKEN, KJETIL;MOUTSCHEN, MICHEL;RAHMOUNI-PIETTE, SOUAD;AANDAHL, EINAR, MARTIN;AUKRUST, PAAL;FROELAND, STIG, S.;JOHANSSON, CHRISTIAN, CARL;HANSSON, VIDAR;KLAVENESS, JO |
